Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis

Immunotherapy resistance is a major barrier in the application of immune checkpoint inhibitors (ICI) in lung adenocarcinoma (LUAD) patients. Although recent studies have found several mechanisms and potential genes responsible for immunotherapy resistance, ways to solve this problem are still lackin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Weina, Liu, Fengsen, Lei, Qingyang, Wu, Peng, Yang, Li, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770266/
https://www.ncbi.nlm.nih.gov/pubmed/35071018
http://dx.doi.org/10.3389/fonc.2021.814014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770266/
https://www.ncbi.nlm.nih.gov/pubmed/35071018
http://dx.doi.org/10.3389/fonc.2021.814014

Ejemplares similares